Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.
Januschowski K, Dimopoulos S, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: dimopoulos s. Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25. Acta Ophthalmol. 2015. PMID: 25619682 Free article. No abstract available.
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group. Jaissle GB, et al. Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21337042 Free PMC article.
Exit strategies in canaloplasty: intraoperative conversion into 180-degree trabeculotomy or 360-degree trabeculotomy in cases of unsuccessful catheterisation of Schlemm's canal: influence of degree of canal cleavage.
Alnahrawy O, Blumenstock G, Ziemssen F, Szurman P, Leitritz MA, Dimopoulos S, Voykov B. Alnahrawy O, et al. Among authors: dimopoulos s. Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):779-84. doi: 10.1007/s00417-015-2955-9. Epub 2015 Feb 18. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25690980
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.
Szurman GB, Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH. Szurman GB, et al. Among authors: dimopoulos s. Acta Ophthalmol. 2017 May;95(3):e245-e246. doi: 10.1111/aos.12976. Epub 2016 Feb 1. Acta Ophthalmol. 2017. PMID: 26833721 Free article. No abstract available.
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
Januschowski K, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: dimopoulos s. Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):457-462. doi: 10.1007/s00417-016-3471-2. Epub 2016 Sep 8. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27632214
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
Szurman GB, Meyer CH, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S, Szurman P; Bevacizumab Study Group Venous Occlusion; Januschowski K. Szurman GB, et al. Among authors: dimopoulos s. Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):1045-1046. doi: 10.1007/s00417-017-3618-9. Epub 2017 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28224287 No abstract available.
208 results